Clinical trial Recruiting at 1 site Observational Ages 18 and up

Registry for patients with spontaneous intracranial hypotension

Official title: Spontaneous Intracranial Hypotension Registry

Run by Mayo Clinic · NCT05922514 · Data updated 2026-11-12

This study is trying to see if a treatment called paraspinal vein embolization can help people with spontaneous intracranial hypotension who have specific fluid leaks in their brain.

More Spontaneous Intracranial Hypotension trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorMayo Clinic
Academic / other
Locations1 site (Rochester, Minnesota)
StatusRecruiting
StartedJune 18, 2023
Main results expectedJuly 2028
Study endsDecember 2028
Registry record updatedAugust 12, 2026
Trial IDNCT05922514 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients diagnosed with SIH who have imaging-confirmed CSF-venous fistulas.

Probably not a fit

Patients who are pregnant, breastfeeding, or have contraindications to the procedure will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather data on patients diagnosed with spontaneous intracranial hypotension (SIH) who have confirmed cerebrospinal fluid-venous fistulas. By utilizing imaging techniques such as digital subtraction myelography (DSM) and CT myelography (CTM), the study seeks to assess the efficacy of paraspinal vein embolization as a treatment option. The findings will help inform the design of future clinical trials targeting this condition. Participants will be monitored for their responses and outcomes over a specified follow-up period.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment options for patients suffering from spontaneous intracranial hypotension.

How similar studies have gone: While this approach is being explored, the efficacy of paraspinal vein embolization for SIH has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Study subjects will be patients who meet the International Classification of Headache - Disorders 3rd Edition (ICHD-3) criteria for a diagnosis of SIH or the Schievink criteria with imaging confirmed CSF-venous fistulas on DSM or CTM.
* Availability of a clinically prescribed contrast enhanced MRI positive for SIH.
* Negative urine or serum pregnancy test at time of study consent and three-months.

Exclusion Criteria:

* Patients who have a contraindication or inability to undergo the procedure (i.e., severe contrast allergy).
* Inability to provide informed consent.
* Expected inability to complete the follow-up assessment.
* Current pregnancy or breast-feeding during study enrollment (from consent to study conclusion approximately 90-days).

Where it's running

  • Mayo Clinic Minnesota
    Rochester, Minnesota, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.